PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,297,293 | -20.5% | 105,300 | -24.8% | 0.58% | -26.1% |
| Q4 2022 | $5,407,331 | -27.4% | 140,050 | 0.0% | 0.79% | -51.4% |
| Q3 2022 | $7,449,000 | -22.2% | 140,050 | -14.7% | 1.62% | -10.8% |
| Q2 2022 | $9,576,000 | -24.7% | 164,250 | -1.5% | 1.82% | +7.3% |
| Q1 2022 | $12,721,000 | +8.4% | 166,675 | -14.5% | 1.70% | +79.0% |
| Q4 2021 | $11,733,000 | +19.7% | 195,000 | +11.4% | 0.95% | +39.3% |
| Q3 2021 | $9,802,000 | -6.4% | 175,038 | +1.4% | 0.68% | +7.9% |
| Q2 2021 | $10,470,000 | -18.3% | 172,538 | -5.6% | 0.63% | -29.2% |
| Q1 2021 | $12,814,000 | +54.8% | 182,824 | +32.2% | 0.89% | +69.8% |
| Q4 2020 | $8,277,000 | +141.9% | 138,324 | +143.0% | 0.52% | +125.9% |
| Q3 2020 | $3,422,000 | +55.5% | 56,924 | +35.8% | 0.23% | 0.0% |
| Q2 2020 | $2,200,000 | – | 41,924 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |